Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Baseline status of O (6)-methylguanine-DNA-methyltransferase (MGMT) promoter methylation and effect of protracted doses of temozolomide on MGMT in acute leukemia. Medeiros, B., Khan, S., Rajwanshi, R., Jones, C., Zehnder, J. AMER ASSOC CANCER RESEARCH. 2009
View details for Web of Science ID 000209702702111